Decrease in α3*/α6* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage
Open Access
- 1 September 2005
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 68 (3) , 737-746
- https://doi.org/10.1124/mol.105.012773
Abstract
Nicotinic acetylcholine receptors (nAChRs) are decreased in the striata of patients with Parkinson's disease (PD) or in experimental models after nigrostriatal damage. Because presynaptic nAChRs on striatal dopamine terminals mediate dopamine release, receptor loss may contribute to behavioral deficits in PD. The present experiments were done to determine whether nAChR function is affected by nigrostriatal damage in nonhuman primates, because this model shares many features with PD. Initial characterization of nicotine-evoked [3H]dopamine release from monkey striatal synaptosomes revealed that release was calcium-dependent and inhibited by selective nAChR antagonists. It is noteworthy that a greater proportion (∼70%) of release was inhibited by the α3*/α6* antagonist α-conotoxinMII (α-CtxMII) compared with rodents. Monkeys were lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and [3H]dopamine release, dopamine transporter, and nAChRs were measured. As anticipated, lesioning decreased the transporter and α3*/α6* nAChRs in caudate and putamen. In contrast, α3*/α6* nAChR-evoked [3H]dopamine release was reduced in caudate but not putamen, demonstrating a dissociation between nAChR sites and function. A different pattern was observed in the mesolimbic dopamine system. Dopamine transporter levels in nucleus accumbens were not reduced after MPTP, as expected; however, there was a 50% decline in α3*/α6* nAChR sites with no decrease in α3*/α6* receptor-evoked dopamine release. No declines in α-CtxMII-resistant nAChR (α4*) binding or nicotine-evoked release were observed in any region. These results show a selective preservation of α3*/α6* nAChR-mediated function in the nigrostriatal and mesolimbic dopamine systems after nigrostriatal damage. Maintenance of function in putamen, a region with a selective loss of dopaminergic terminals, may be important in PD.Keywords
This publication has 36 references indexed in Scilit:
- Effect of Novel α-Conotoxins on Nicotine-Stimulated [3H]Dopamine Release from Rat Striatal SynaptosomesThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Subunit Composition of Nicotinic Receptors in Monkey Striatum: Effect of Treatments with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPAMolecular Pharmacology, 2005
- Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in MiceMolecular Pharmacology, 2004
- Nicotine-Induced Dopamine Release in Primates Measured with [11C]Raclopride PETNeuropsychopharmacology, 2003
- Differential Inhibition by α‐Conotoxin‐MII of the Nicotinic Stimulation of [3H]Dopamine Release from Rat Striatal Synaptosomes and SlicesJournal of Neurochemistry, 1998
- Presynaptic nicotinic ACh receptorsPublished by Elsevier ,1997
- A New α-Conotoxin Which Targets α3β2 Nicotinic Acetylcholine ReceptorsJournal of Biological Chemistry, 1996
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyAnnals of Neurology, 1990
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988